Overview

Nazia Khan is an associate in the Corporate Practice Group in the firm's Washington D.C. office.

Areas of Practice

Ms. Khan’s practice focuses on corporate finance and securities laws. Ms. Khan represents underwriters and companies in various industries including technology, cannabis, life sciences, healthcare, food and beverage, transportation and REITs in capital markets transactions. Her experience includes leading both underwriters as well as domestic and foreign companies in public and private corporate finance transactions, including initial public offerings, shelf registrations, registered direct transactions, private investments in public equity (PIPEs), private placements and other securities offerings. In addition, Ms. Khan’s experience includes initial public offerings of SPACs as well as de-SPAC transactions. She also represents publicly held companies with their reporting obligations under the Exchange Act and with NASDAQ, NYSE and other exchange listing and compliance matters including matters involving FINRA.

Experience

Experience

Traditional IPOs:

  • Represented Immix Biopharma, Inc. in its initial public offering and listing on Nasdaq
  • Represented Greenwich LifeSciences, Inc. in its initial public offering and listing on Nasdaq
  • Represented Hoth Therapeutics, Inc. in its initial public offering and listing on Nasdaq
  • Represented Immuron Limited in its initial public offering and listing on Nasdaq
  • Represented Aridis Pharmaceuticals, Inc., in its initial public offering and listing on Nasdaq
  • Represented underwriters in an initial public offering and listing on Nasdaq of a company in the rideshare industry
  • Represented underwriters in an initial public offering of and listing on Nasdaq of a biotechnology company focused on early cancer screening and detection

SPACs:

  • Represented A.G.P./Alliance Global Partners in an initial public offering and listing on NYSE American of Ault Disruptive Technologies Corporation
  • Represented A.G.P./Alliance Global Partners in an initial public offering and listing on Nasdaq of Digital Health Acquisition Corp.

Other Transactions:

  • Represented Majesco in sale to private equity firm for $729 million.

Honors

Honors

New York Metro Rising Stars, Super Lawyers, 2017-2021

Ones to Watch — Corporate Law, Best Lawyers, 2021, 2022

Who's Who in America, 2019

Insights

Media Mentions

Memberships

Memberships

  • Board Member, Ms. JD, Mentor
  • Leadership Counsel on Legal Diversity

Education

J.D., California Western School of Law, 2013, with honors

B.S., George Mason University, 2010, cum laude

Admissions

  • Texas
  • New York
  • New Jersey
  • Not admitted in District of Columbia; supervised by partners of the firm admitted in the District of Columbia.

Languages

Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.